Martijn P. Lolkema
Amgen (United States)(US)University of California, Los Angeles(US)Erasmus MC(NL)Center for Personalized Cancer Treatment(NL)Erasmus MC Cancer Institute(NL)Amgen (Netherlands)(NL)
Publications by Year
Research Areas
Prostate Cancer Treatment and Research, Cancer Genomics and Diagnostics, Cancer Immunotherapy and Biomarkers, CAR-T cell therapy research, Radiopharmaceutical Chemistry and Applications
Most-Cited Works
- → Natural adjuvants: Endogenous activators of dendritic cells(1999)1,592 cited
- → Pan-cancer whole-genome analyses of metastatic solid tumours(2019)1,157 cited
- → Recommendations for the use of next-generation sequencing (NGS) for patients with metastatic cancers: a report from the ESMO Precision Medicine Working Group(2020)1,151 cited
- → Hyaluronan impairs vascular function and drug delivery in a mouse model of pancreatic cancer(2012)1,060 cited
- → Stromal biology and therapy in pancreatic cancer(2010)748 cited
- → nab -Paclitaxel Potentiates Gemcitabine Activity by Reducing Cytidine Deaminase Levels in a Mouse Model of Pancreatic Cancer(2012)424 cited